Top

Published in:

01-11-2010 | Review Article

Genetic aspects of osteoporosis

Author: Takayuki Hosoi

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2010

Abstract

The multiple factors contributing to the pathogenesis of osteoporosis include genetic and environmental factors. Because decrease in bone mineral density (BMD) is the major clinical indicator and a useful quantitative trait, many association and linkage studies of BMD have been conducted. Although the series of studies showed apparently significant associations, the genes have not been found that can be utilized in clinical practice. Several genes identified in robust genome-wide association studies will be the new cutting edge in genetic studies of osteoporosis. Our recent reports of functional single nucleotide polymorphism in the tissue-nonspecific alkaline phosphatase gene and gamma-carboxylase gene are presented in this review to discuss the future prospects in the genetic research of osteoporosis from the point of view of genome–nutrition interaction.

Kroth PJ, Murray MD, McDonald CJ (2004) Undertreatment of osteoporosis in women, based on detection of vertebral compression fractures on chest radiography. Am J Geriatr Pharmacother 2:112–118CrossRefPubMed

Consensus Development Center (1993) Consensus Development Conference V, 1993. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650

NIH Consensus Development Panel (2001) NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–793

Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variation in hip fracture probabilities: implication for risk assessment. J Bone Miner Res 17:1237–1244CrossRefPubMed

Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S (1987) Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706–710CrossRefPubMed

Andrew T, Antioniades L, Scurrah KJ, Macgregor AJ, Spector TD (2005) Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. J Bone Miner Res 20:67–74CrossRefPubMed

Xiong DH, Shen H, Xiao P, Gua YF, Long JR, Zhao LJ, Liu YZ, Deng HY, Li JL, Recker RR, Deng HW (2006) Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis. J Bone Miner Res 21:424–437CrossRefPubMed

Liu YJ, Shen H, Xiao P, Xiong DH, Li LH, Recker RR, Deng HW (2006) Molecular genetics of gene identification for osteoporosis: a 2004 update. J Bone Miner Res 21:1511–1535CrossRefPubMed

Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378–383CrossRefPubMed

10.

Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H (1996) Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306–311CrossRefPubMed

11.

Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y (1997) Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1:1438–1445CrossRef

12.

Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki I, Inoue S, Shiraki M, Ouchi Y (1997) Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone (NY) 21:379–383

13.

Hosoi T, Miyao M, Inoue S, Hoshino S, Shiraki M, Orimo H, Ouchi Y (1999) Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 64:205–208CrossRefPubMed

14.

Miyao M, Hosoi T, Inoue S, Hoshino S, Shiraki M, Orimo H, Ouchi Y (1998) Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcif Tissue Int 63:306–311CrossRefPubMed

15.

Ota N, Hunt SC, Nakajima T, Suzuki T, Hosoi T, Orimo H, Shirai Y, Emi M (1999) Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis. Hum Genet 105:253–257CrossRefPubMed

16.

Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, Shiraki M, Orimo H, Ouschi Y, Inoue S (1999) Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPAR gamma expression in osteoblasts. Biochem Biophys Res Commun 260:122–126CrossRefPubMed

17.

Nakajima T, Ota N, Shirai Y, Hata A, Yoshida H, Suzuki T, Hosoi T, Orimo H, Emi M (1999) Ethnic difference in contribution of Sp1 site variation of COL1A1 gene in genetic predisposition to osteoporosis. Calcif Tissue Int 65:352–353CrossRefPubMed

18.

Tsukamoto K, Orimo H, Hosoi T, Miyao M, Yoshida G, Watanabe S, Suzuki T, Emi M (2000) Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J Bone Miner Metab 18:27–30CrossRefPubMed

19.

Tsukamoto K, Orimo H, Hosoi T, Miyao M, Ota N, Nakajima T, Yoshida H, Watanabe S, Suzuki T, Emi M (2000) Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus. Calcif Tissue Int 66:181–183CrossRefPubMed

20.

Urano T, Hosoi T, Shiraki M, Toyoshima H, Ouchi Y, Inoue S (2000) Possible involvement of the p57 (Kip2) gene in bone metabolism. Biochem Biophys Res Commun 269:422–426CrossRefPubMed

21.

Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Ohta H, Shiraki M (2000) Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415–420CrossRefPubMed

22.

Ogawa S, Hosoi T, Shiraki M, Orimo H, Emi M, Muramatsu M, Ouchi Y, Inoue S (2000) Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 269:537–541CrossRefPubMed

23.

Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66:190–194CrossRefPubMed

24.

Miyao M, Hosoi T, Emi M, Nakajima T, Inoue S, Hoshino S, Shiraki M, Orimo H, Ouchi Y (2000) Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus. J Hum Genet 45:346–350CrossRefPubMed

25.

Ota N, Hunt SC, Nakajima T, Suzuki T, Hosoi T, Orimo H, Shirai Y, Emi M (2000) Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib pair analysis. Genes Immun 1:260–264CrossRefPubMed

26.

Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M (2001) A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 46:267–272CrossRefPubMed

27.

Ogata N, Shiraki M, Hosoi T, Koshizuka Y, Nakamura K, Kawaguchi H (2001) A polymorphic variant at the Werner helicase (WRN) gene is associated with bone density, but not spondylosis, in postmenopausal women. J Bone Miner Metab 19:296–301CrossRefPubMed

28.

Ogata N, Matsumura Y, Shiraki M, Kawano K, Koshizuka Y, Hosoi T, Nakamura K, Kuro-O M, Kawaguchi H (2002) Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone (NY) 31:37–42

29.

Ohmori H, Makita Y, Funamizu M, Hiooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A (2002) Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. J Hum Genet 47:400–406CrossRefPubMed

30.

Kawano K, Ogata N, Chiano M, Molloy H, Kleyn P, Spector TD, Uchida M, Hosoi T, Suzuki T, Orimo H, Inoue S, Nabeshima Y, Nakamura K, Kuro-o M, Kawaguchi H (2002) Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res 17:1744–1751CrossRefPubMed

31.

Ota N, Nakajima T, Ezura Y, Iwasaki H, Suzuki T, Hosoi T, Orimo H, Inoue S, Ito H, Emi M (2002) Association of a single nucleotide variant in the human tumor necrosis factor-alpha promoter region with decreased bone mineral density. Ann Hum Biol 29:550–558CrossRefPubMed

32.

Ezura Y, Nakajima T, Kajita M, Ishida R, Inoue S, Yoshida H, Suzuki T, Shiraki M, Hosoi T, Orimo H, Emi M (2003) Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 18:1642–1649CrossRefPubMed

33.

Feng D, Ishibashi H, Yamamoto S, Hosoi T, Orimo H, Machida T, Koshihara Y (2003) Association between bone loss and promoter polymorphism in the Japanese women with hip fracture. J Bone Miner Metab 21:225–228PubMed

34.

Omasu F, Ezura Y, Kajita M, Ishida R, Kodaira M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Orimo H, Emi M (2003) Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women. J Hum Genet 48:342–345CrossRefPubMed

35.

Ezura Y, Kajita M, Ishida R, Yoshida S, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Orimo H, Emi M (2004) Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women. J Bone Miner Res 19:1296–1301CrossRefPubMed

36.

Ishida R, Ezura Y, Emi M, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Ito H, Orimo H (2003) Association of a promoter haplotype (-1542G/-525C) in the tumor necrosis factor receptor associated factor-interacting protein gene with low bone mineral density in Japanese women. Bone (NY) 33:237–241

37.

Urano T, Shiraki M, Fujita M, Hosoi T, Orimo H, Ouchi Y, Inoue S (2005) Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5’-flanking region (-5229G/A) with bone mineral density. J Bone Miner Metab 23:226–230CrossRefPubMed

38.

Sudo Y, Ezura Y, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shirak M, Ito H, Emi M (2005) Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women. J Hum Genet 50:235–240CrossRefPubMed

39.

Mori S, Kou I, Sato H, Emi M, Ito H, Hosoi T, Ikegawa S (2008) Association of genetic variations of genes encoding thrombospondin, type 1, domain-containing 4 and 7A with low bone mineral density in Japanese women with osteoporosis. J Hum Genet 53:694–697CrossRefPubMed

40.

Mori S, Kou I, Sato H, Emi M, Ito H, Hosoi T, Ikegawa S (2009) Nucleotide variations in genes encoding carbonic anhydrase 8 and 10 associated with femoral bone mineral density in Japanese females with osteoporosis. J Bone Miner Metab 27:213–216CrossRefPubMed

41.

Shen H, Liu YJ, Liu PY, Recker RR, Deng HW (2005) Non-replication in genetic studies of complex diseases: lessons learned from studies of osteoporosis and tentative remedies. J Bone Miner Res 20:365–376CrossRefPubMed

42.

Ionnidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ionnidis DG (2003) Genetic association in large versus small studies: an empirical assessment. Lancet 361:567–571CrossRef

43.

Deng HW (2001) Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits. Genetics 159:1319–1323PubMed

44.

Thakkinstian S, D’Este C, Eisman J, Nguen T, Attia J (2004) Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 19:419–426CrossRefPubMed

45.

Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, EPOS Investigators; EPOLOS Investigators; FAMOS Investigators; LASA Investigators; Rotterdam Study Investigators; GENOMOS Study et al (2006) The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med 145:255–264PubMed

46.

Goseki-Sone M, Sogabe N, Fukushi-Irie M, Mizoi L, Orimo H, Suzuki T, Nakamura H, Orimo H, Hosoi T (2005) Functional analysis of the single-nucleotide polymorphism (787T>C) in tissue-nonspecific alkaline phosphatase gene associated with bone mineral density. J Bone Miner Res 20:773–778CrossRefPubMed

47.

Sogabe N, Oda K, Nakamura H, Orimo H, Watanabe H, Hosoi T, Goseki-Sone M (2008) Molecular effects of the tissue-nonspecific alkaline phosphatase gene polymorphism (787T>C) associated with bone mineral density. Biomed Res 29:213–219CrossRefPubMed

48.

Orimo H, Goseki-Sone M, Hosoi T, Shimada T (2008) Functional analysis of the mutant tissue-nonspecific alkaline phosphatase gene using U2OS osteoblast-like cells. Mol Genet Metab 94:375–381CrossRefPubMed

49.

Kinoshita H, Nakagawa K, Narusawa K, Goseki-Sone M, Fukushi-Irie M, Mizoi L, Yoshida H, Okano T, Nakamura T, Suzuki T, Inoue S, Orimo H, Ouchi Y, Hosoi T (2007) A functional single nucleotide polymorphism in the vitamin K-dependent gamma-glutamyl carboxylase gene (Arg325Glu) is associated with bone mineral density in elderly Japanese women. Bone (NY) 40:451–456

50.

Sogabe N, Tsugawa N, Maruyama R, Kamao M, Kinoshita H, Okano T, Hosoi T, Goseki-Sone M (2007) Nutritional effects of gamma-glutamyl carboxylase gene polymorphism on the correlation between the vitamin K status and gamma-carboxylation of osteocalcin in young males. J Nutr Sci Vitaminol (Tokyo) 53:419–425CrossRef

51.

Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Osteoporosis-Pseudoglioma Syndrome Collaborative Group et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523CrossRefPubMed

52.

Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513–1521CrossRefPubMed

53.

Koller DL, Econs MJ, Morin PA, Christian JC, Hui SL, Parry P, Curran ME, Rodriguez LA, Conneally PM, Joslyn G, Peacock M, Johnston CC, Foroud T (2000) Genome screen for QTLs contributing to normal variation in bone mineral density. J Clin Endocrinol Metab 85:3116–3120CrossRefPubMed

54.

Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, Inoue S (2004) Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J Bone Miner Metab 22:341–345CrossRefPubMed

55.

Audrey Koay M, Brown MA (2005) Genetic disorders of the LRP5–Wnt signalling pathway affecting the skeleton. Trends Mol Med 11:129–137CrossRefPubMed

56.

Ezura Y, Nakajima T, Urano T, Sudo Y, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Emi M (2007) Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor protein 5 gene (LRP5) with bone mineral density in adult Japanese women. Bone (NY) 40:997–1005

57.

Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L et al (2009) Genome-wide association study and follow-up replication studies identified ADAMTS18 an TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet 84:388–398CrossRefPubMed

58.

Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N et al (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371:1505–1512CrossRefPubMed

59.

Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355–2365CrossRefPubMed

60.

Kung AW, Xiao SM, Chemy S, Li GH, Gao Y et al (2010) Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet 86:229–239CrossRefPubMed

Title: Genetic aspects of osteoporosis
Author: Takayuki Hosoi
Publication date: 01-11-2010
Publisher: Springer Japan
Published in: Journal of Bone and Mineral Metabolism / Issue 6/2010
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-010-0217-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Genetic aspects of osteoporosis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2010

LIST OF REVIEWERS 2009–2010

Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget’s disease

Lymphocyte enhancer-binding factor 1: an essential factor in odontoblastic differentiation of dental pulp cells enzymatically isolated from rat incisors

Densitometric and geometric measurement of the proximal femur in elderly women with and without osteoporotic vertebral fractures by volumetric quantitative multi-slice CT

Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate

Intermittent weekly administration of human parathyroid hormone (1–34) improves bone-hydroxyapatite block bonding in ovariectomized rats

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page